Clinical Trial Update: The GAPSID Study - How GLP-1 Analogues Prevent Steroid-Induced Diabetes [NA]

View source ↗

Summary

Imperial College London is conducting a trial to test whether GLP-1 analogues can prevent steroid-induced diabetes in at-risk patients; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Steroid-induced Diabetes Mellitus
• Steroid-induced Hyperglycemia

Drugs mentioned

• GLP-1 analogue (GLP-1 analogue)

Snippet

Sponsor: Imperial College London | Conditions: Steroid-Induced Diabetes, Steroid Induced Hyperglycemia | NA | Status: RECRUITING